# To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold

> **NCT03005067** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 171 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Carbomer 980 (1146A)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03005067
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-29
- **Primary completion:** 2017-06-07
- **Final completion:** 2017-06-07
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03005067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03005067, "To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03005067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*